| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 1.000 | None | 0.983 | 1637 | 35 | 1986 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.800 | strong | 0.950 | 535 | 32 | 1994 | 2020 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.500 | None | 0.967 | 183 | 23 | 1992 | 2020 | ||||||||
|
melanocortin 1 receptor | 0.524 | 0.808 | 8.1E-11 |
|
disease | 0.500 | None | 0.959 | 194 | 15 | 1996 | 2020 | ||||||||
|
mitogen-activated protein kinase kinase 1 | 0.439 | 0.846 | 0.90 |
|
disease | 0.700 | None | 1.000 | 44 | 15 | 2003 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.943 | 209 | 13 | 1991 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.500 | None | 0.986 | 70 | 12 | 1996 | 2020 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.700 | None | 0.969 | 321 | 10 | 1987 | 2020 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.500 | None | 0.870 | 23 | 9 | 1996 | 2019 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
disease | 0.100 | None | 0.974 | 38 | 8 | 1999 | 2019 | ||||||||
|
melanocyte inducing transcription factor | 0.499 | 0.808 | 0.98 |
|
disease | 0.700 | None | 0.974 | 194 | 7 | 2002 | 2020 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.800 | None | 1.000 | 25 | 6 | 1984 | 2018 | ||||||||
|
methylthioadenosine phosphorylase | 0.514 | 0.731 | 7.6E-08 |
|
disease | 0.500 | None | 1.000 | 19 | 6 | 1995 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 4 | 0.455 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.917 | 12 | 6 | 2009 | 2018 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
disease | 0.490 | None | 1.000 | 9 | 6 | 2007 | 2017 | ||||||||
|
AFG3 like matrix AAA peptidase subunit 1, pseudogene | 0.931 | 0.115 |
|
disease | 0.100 | None | 1.000 | 4 | 6 | 2009 | 2017 | |||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
disease | 0.500 | None | 1.000 | 77 | 5 | 2002 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase 2 | 0.534 | 0.731 | 0.97 |
|
disease | 0.670 | None | 1.000 | 9 | 5 | 2011 | 2019 | ||||||||
|
tyrosinase | 0.473 | 0.808 | 5.0E-32 |
|
disease | 0.500 | None | 0.984 | 191 | 4 | 1988 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.800 | strong | 0.950 | 101 | 4 | 1997 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.100 | None | 0.979 | 47 | 4 | 1991 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.700 | strong | 1.000 | 47 | 4 | 2001 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.200 | None | 1.000 | 25 | 4 | 2001 | 2020 | ||||||||
|
solute carrier family 45 member 2 | 0.626 | 0.538 | 1.7E-06 |
|
disease | 0.500 | None | 0.950 | 20 | 4 | 1996 | 2019 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
disease | 0.700 | None | 1.000 | 15 | 4 | 1999 | 2018 |